Sensitivity of Various Evaluating Modalities for Predicting a Pathologic Complete Response After Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer

다국어 초록 (Multilingual Abstract)

Purpose: We investigated the sensitivity of various evaluating modalities in predicting a pathologic complete response (pCR) after preoperative chemoradiation therapy (PCRT) for locally advanced rectal cancer (LARC). Methods: From a population of 2,247 LARC patients who underwent PCRT followed by surgery at Asan Medical Center, Seoul, Korea from January 2007 to June 2016, we retrospectively analyzed 313 patients (14.1%) who showed a pCR after surgery. Transrectal ultrasound (TRUS), high-resolution magnetic resonance imaging (MRI), abdominopelvic computed tomography (AP-CT), and endoscopy were performed within 2 weeks prior to surgery. Results: Of the 313 patients analyzed, 256 (81.8%) had a pCR after radical surgery and 57 (18.2%) showed total regression after local excision. Preoperative TRUS, MRI, and AP-CT were performed in 283, 305, and 139 patients, respectively. Among these 3 groups, a prediction of a pCR of the primary tumor was made in 41 (14.5%), 51 (16.7%), and 27 patients (19.4%), respectively, before surgery. A prediction of a clinical N0 stage was made in 204 patients (88.3%) using TRUS, 130 (52.2%) using MRI, and 78 (65.5%) using AP-CT. Of the 211 patients who underwent endoscopy, 87 (41.2%) had a mention of clinical CR in their records. A prediction of a pathologic CR was made for 124 patients (39.6%) through at least one diagnostic modality. Conclusion: The various evaluation methods for predicting a pCR after PCRT show a predictive sensitivity of 0.15–0.41 for primary tumors and 0.52–0.88 for lymph nodes. Endoscopy is a relatively superior modality for predicting the pCR of the primary tumor of LARC patients.

참고문헌 (Reference)

1 Habr-Gama A, "Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer : are we getting closer to anal cancer management?" 56 : 1109-1117, 2013

2 Maas M, "Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer" 29 : 4633-4640, 2011

3 West MA, "Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer-A comparison of magnetic resonance imaging at two time points and histopathological responses" 42 : 1350-1358, 2016

4 Maretto I, "The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer" 14 : 455-461, 2007

5 Edge SB, "The American Joint Committee on Cancer : the 7th edition of the AJCC cancer staging manual and the future of TNM" 17 : 1471-1474, 2010

6 Memon S, "Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy" 17 : 748-761, 2015

7 Benson AB 3rd, "Rectal cancer, version 2.2015" 13 : 719-728, 2015

8 Curvo-Semedo L, "Rectal cancer : assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging" 260 : 734-743, 2011

9 Beets-Tan RG, "Preoperative assessment of local tumor extent in advanced rectal cancer : CT or high-resolution MRI?" 25 : 533-541, 2000

10 Kawai K, "Prediction of pathological complete response using endoscopic findings and outcomes of patients who underwent watchful waiting after chemoradiotherapy for rectal cancer" 60 : 368-375, 2017

11 Pomerri F, "Prediction of N0 irradiated rectal cancer comparing mri before and after preoperative chemoradiotherapy" 60 : 1184-1191, 2017

12 Ryan JE, "Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer : a systematic review" 18 : 234-246, 2016

13 van der Paardt MP, "Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging : a systematic review and meta-analysis" 269 : 101-112, 2013

14 Dworak O, "Pathological features of rectal cancer after preoperative radiochemotherapy" 12 : 19-23, 1997

15 Heijnen LA, "Nodal staging in rectal cancer : why is restaging after chemoradiation more accurate than primary nodal staging?" 31 : 1157-1162, 2016

16 Guillem JG, "Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer : a prospective study" 258 : 289-295, 2013

17 Hötker AM, "Multiparametric MRI of rectal cancer in the assessment of response to therapy : a systematic review" 57 : 790-799, 2014

18 Bhoday J, "Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy" 59 : 925-933, 2016

19 Patel UB, "Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes : MERCURY experience" 29 : 3753-3760, 2011

20 Perez RO, "Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation?" 52 : 1278-1284, 2009

21 Maas M, "Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer : a pooled analysis of individual patient data" 11 : 835-844, 2010

22 Yu CS, "Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer : a national multicenter analysis" 206 : 482-487, 2013

23 Akasu T, "Limitations and pitfalls of transrectal ultrasonography for staging of rectal cancer" 40 (40): S10-S15, 1997

24 KSAR Study Group for Rectal Cancer, "Essential Items for Structured Reporting of Rectal Cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology" 대한영상의학회 18 (18): 132-151, 2017

25 Lambregts DM, "Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer : a multicenter study" 18 : 2224-2231, 2011

26 Habr-Gama A, "Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer : characterization of clinical and endoscopic findings for standardization" 53 : 1692-1698, 2010

27 Rau B, "Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer" 13 : 980-984, 1999

28 Huh JW, "Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation" 207 : 7-12, 2008

29 van den Broek JJ, "Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation" 60 : 274-283, 2017

30 García-Aguilar J, "A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision" 46 : 298-304, 2003